Editorial: monitoring vedolizumab trough serum concentration in inflammatory bowel disease-following the fate of anti-TNF-alpha agents?

Editorial: monitoring vedolizumab trough serum concentration in inflammatory bowel disease-following the fate of anti-TNF-alpha agents?

Aliment Pharmacol Ther. 2018 May;47(9):1323-1324

Authors: Fragaki M, Karmiris K

PMID: 29644739 [PubMed – in process]

PubMed Link: https://www.ncbi.nlm.nih.gov/pubmed/29644739?dopt=Abstract